Previous 10 | Next 10 |
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indica...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indi...
2023-12-29 15:49:49 ET More on Virpax Pharmaceuticals Virpax Pharmaceuticals gets non-compliance notice from Nasdaq Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Financial information for Vir...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barriers, to...
2023-11-17 08:41:25 ET More on Virpax Pharmaceuticals Virpax slips as court rules in favor of Scilex and Sorrento Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Financial information for Virpa...
2023-11-17 07:38:01 ET More on Virpax Pharmaceuticals Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Financial information for Virpax Pharmaceuticals For further details see: Virpax Pharma...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barriers, to...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indi...
2023-11-15 18:02:42 ET Virpax Pharmaceuticals press release ( NASDAQ: VRPX ): Q3 GAAP EPS of -$0.51. As of September 30, 2023, cash and cash equivalents were $12.2 million. For further details see: Virpax Pharmaceuticals GAAP EPS of -$0.51
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indica...
News, Short Squeeze, Breakout and More Instantly...
Virpax Pharmaceuticals Inc. Company Name:
VRPX Stock Symbol:
NASDAQ Market:
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indicatio...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 147.2% to $0.705 on volume of 1,314,512,517 shares SiNtx Technologies Inc. (SINT) rose 132.0% to $0.1276 on volume of 976,185,336 shares Greenwave Technology Solutions Inc. (GWAV) r...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...